BiotechTube

Eleclazine + Placebo to match eleclazine

Phase 2Completed
1 views this week 0 watching💤 Quiet
Interest: 35/100
35
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Ventricular Arrhythmia

Conditions

Ventricular Arrhythmia

Trial Timeline

Sep 1, 2014 → Oct 1, 2016

NCT ID
NCT02104583

About Eleclazine + Placebo to match eleclazine

Eleclazine + Placebo to match eleclazine is a phase 2 stage product being developed by Gilead Sciences for Ventricular Arrhythmia. The current trial status is completed. This product is registered under clinical trial identifier NCT02104583. Target conditions include Ventricular Arrhythmia.

What happened to similar drugs?

2 of 11 similar drugs in Ventricular Arrhythmia were approved

Approved (2) Terminated (2) Active (7)
✅Beta-blocker treatment groupNovo NordiskApproved
✅Definity® Vial for (Perflutren Lipid Microsphere) Injectable SuspensionLantheus HoldingsApproved
🔄Valsartan + Amlodipine + Hydrochlorothiazide + LosartanNovartisPhase 3
🔄Finerenone (Kerendia, BAY94-8862)BayerPhase 3
🔄Finerenone (Kerendia, BAY94-8862) + PlaceboBayerPhase 3
❌Etripamil + Placebo + Etripamil Test DoseMedpacePhase 3
❌Etripamil NS 70 mgMedpacePhase 3

Hype Score Breakdown

Clinical
12
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT02104583Phase 2Completed

Competing Products

20 competing products in Ventricular Arrhythmia

See all competitors
ProductCompanyStageHype Score
ONO-1101Ono PharmaceuticalPhase 2
35
ONO-1101Ono PharmaceuticalPhase 2/3
38
Valsartan + Amlodipine + Hydrochlorothiazide + LosartanNovartisPhase 3
40
ranolazineGilead SciencesPhase 2
35
Beta-blocker treatment groupNovo NordiskApproved
50
DIC075VPfizerPhase 1
29
Finerenone (BAY94-8862): intervention A + Finerenone (BAY94-8862): intervention BBayerPhase 1
26
Finerenone (Kerendia, BAY94-8862)BayerPhase 3
44
Finerenone (Kerendia, BAY94-8862) + PlaceboBayerPhase 3
44
Inhaled Iloprost + PlaceboBayerPhase 2
24
Etripamil + Placebo + Etripamil Test DoseMedpacePhase 3
29
Etripamil NS 70 mgMedpacePhase 3
29
Etripamil + PlaceboMedpacePhase 2
32
LevosimendanOrion CorporationPre-clinical
23
Definity® Vial for (Perflutren Lipid Microsphere) Injectable SuspensionLantheus HoldingsApproved
40
Flecainide (monotherapy)Brain BiotechPre-clinical
23
MK0954, /Duration of Treatment : 5 Years + Comparator : atenolol /Duration of Treatment : 5 YearsOrganonPhase 3
34
SGT-501Solid BiosciencesPhase 1
30
Etripamil NS 70 mg + PlaceboMilestone PharmaceuticalsPhase 3
30
Etripamil NSMilestone PharmaceuticalsPhase 3
30